Morning and evening symptoms were numerically reduced on challenge days two through five in patients receiving AZD8848 (60 μg), but these effects failed to reach statistical significance (Figure 6 ): p > 0.05 for morning as well as evening symptoms.
← all excerpts
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.
1
0.0500
0.0500